Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Advances in Experimental Medicine and Biology
|
March 26, 2014
Antioxidant therapy for retinal disease
Anna-Sophia Kiang, Marian M Humphries, Matthew Campbell, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
Inflammation in age-related macular degeneration
Ema Ozaki, Matthew Campbell, Anna-Sophia Kiang, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
Current therapeutic strategies for P23H RHO-linked RP
Anh T H Nguyen, Matthew Campbell, Anna-Sophia Kiang, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
An overview of the involvement of interleukin-18 in degenerative retinopathies
Matthew Campbell, Sarah L Doyle, Ema Ozaki, et al.
Molecular Therapy. Methods & Clinical Development
|
April 15, 2025
Enhanced retinal pigment epithelial cells as a delivery vehicle for retinal disease
Avril Reddy, Chris Greene, Yosuke Hashimoto, et al.
Genes
|
December 2, 2020
Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa
Anna-Sophia Kiang, Paul F Kenna, Marian M Humphries, et al.
Advances in Experimental Medicine and Biology
|
March 19, 2010
Protection of photoreceptors in a mouse model of RP10
Lawrence C S Tam, Anna-Sophia Kiang, Naomi Chadderton, et al.
Human Molecular Genetics
|
September 7, 2010
Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)
Lawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2004
RNAi of COL1A1 in mesenchymal progenitor cells
Sophia Millington-Ward, Helena P McMahon, Danny Allen, et al.
BMJ Open Ophthalmology
|
May 20, 2020
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy
Paul F Kenna, Marian M Humphries, Anna-Sophia Kiang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Advances in Experimental Medicine and Biology
|
March 26, 2014
Antioxidant therapy for retinal disease
Anna-Sophia Kiang, Marian M Humphries, Matthew Campbell, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
Inflammation in age-related macular degeneration
Ema Ozaki, Matthew Campbell, Anna-Sophia Kiang, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
Current therapeutic strategies for P23H RHO-linked RP
Anh T H Nguyen, Matthew Campbell, Anna-Sophia Kiang, et al.
Advances in Experimental Medicine and Biology
|
March 26, 2014
An overview of the involvement of interleukin-18 in degenerative retinopathies
Matthew Campbell, Sarah L Doyle, Ema Ozaki, et al.
Molecular Therapy. Methods & Clinical Development
|
April 15, 2025
Enhanced retinal pigment epithelial cells as a delivery vehicle for retinal disease
Avril Reddy, Chris Greene, Yosuke Hashimoto, et al.
Genes
|
December 2, 2020
Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa
Anna-Sophia Kiang, Paul F Kenna, Marian M Humphries, et al.
Advances in Experimental Medicine and Biology
|
March 19, 2010
Protection of photoreceptors in a mouse model of RP10
Lawrence C S Tam, Anna-Sophia Kiang, Naomi Chadderton, et al.
Human Molecular Genetics
|
September 7, 2010
Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)
Lawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
European Journal of Human Genetics : EJHG
|
July 9, 2004
RNAi of COL1A1 in mesenchymal progenitor cells
Sophia Millington-Ward, Helena P McMahon, Danny Allen, et al.
BMJ Open Ophthalmology
|
May 20, 2020
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy
Paul F Kenna, Marian M Humphries, Anna-Sophia Kiang, et al.
Page
of 3